2018 Annual Conference Oral and Poster Presentations

2018 Annual Conference Oral and Poster Presentations

TUESDAY MAIN CONFERENCE

SectionAbstract NumberSession
6/12
CONFERENCE: Day 1
Keynote: Cancer Registry is a Marathon: Matt Jones

Plenary Session #1: Bridge to the Future

1PL1Advances in Precision Medicine and Immunotherapy: What Cancer Registries Need to Know About Advances in Oncology; Dr. Jonathan C. Silverstein University of Pittsburgh School of Medicine
1PL2CAR-T Therapy and Other Advances in Immunotherapy; Dr. Kathleen Dorritie, University of Pittsburgh, Department of Medicine/Division of Hematology-Oncology
2018 Presentation of the NAACCR Membership Recognition Awards
NAACCR YOUNG Talk
NYT15105Doing More with Less: Medicaid Administrative Claiming: L Giljahn, Ohio Department of Health, Columbus, OH, United States

Concurrent Session #1

Concurrent 1-AEpidemiology I
1A15108Development and Refinement of Recurrence Identification at a Population Level Using Routine Healthcare Datasets: J Charnock, Macmillan Cancer Support, London, Great Britain, Public Health England, London, Great Britain
1A25004The Epidemiology of Lung Cancer in Israel 1990 - 2014: B Silverman, Israel National Cancer Registry, Israel Ministry of Health, Tel HaShomer, Israel
1A35134Factors Associated with Primary Tumor Resection in Stage IV Colon Cancer Patients: A SEER Patterns of Care Analysis: M Charlton, University of Iowa, Iowa City, IA, United States, Iowa Cancer Registry, Iowa City, IA, United States
1A45056Wait Time to Surgery and Survival Among Colorectal and Lung Cancer Patients in Ontario: T Navaneelan, Cancer Care Ontario, Toronto, ON, Canada
1A55135Treatment-Related Tools for Cancer Surveillance and Research: The Observational Research in Oncology Toolbox and SEER*Rx: D Rivera, National Cancer Institute, Rockville, MD, United States
Concurrent 1-BSurvival Studies
1B15091Survival among Native American Adolescent and Young Adult Cancer Patients in California: C Morris, UC Davis, Sacramento, CA, United States
1B25124Re-evaluating Cancer Survival Trends among Adolescents and Young Adults in the United States: L Liu, Los Angeles Cancer Surveillance Program, University of Southern California, Los Angeles, CA, United States
1B35155Ethnic Disparities in Melanoma Diagnosis and Survival: The Effects of Socioeconomic Status and Health Insurance Coverage: A Anderson-Mellies, University of Colorado Cancer Center, Aurora, CO, United States
1B45143Cancer Incidence, by Stage, in Canada: S Bryan, Statistics Canada, Ottawa, ON, Canada
Concurrent 1-CThe Long and Winding Road: Natural Language Processing
1C15100Uncertainty Quantification: Characterizing the Sources of Error in Automated Information Extraction from Pathology Reports: B McMahon, Los Alamos National Laboratory, Los Alamos, NM, United States
1C25093Combining Machine Learning and Uncertainty Quantification (UQ) to Develop Triage Rules to Partially Automate Registry Workflow: N Hengartner, Los Alamos National Laboratory, Los Alamos, NM, United States
1C35126DeepPhe - A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records: G Savova, Boston Children's Hospital, Boston, MA, United States, Harvard Medical School, Boston, MA, United States
1C45128Capturing High-Resolution Temporal Cancer Phenotypes using DeepPhe: H Hochheiser, University of Pittsburgh, Pittsburgh, PA, United States
1C55125A Comprehensive Ontology of Hematology/Oncology Treatment Regimens: JL Warner, HemOnc.org LLC, Lexington, MA, United States, Vanderbilt University Medical Center, Nashville, TN, United States, Vanderbilt University, Nashville, TN, United States
Concurrent 1-DFinding Home: Advances in Residential History Data
1D15078Integration of Individual Residential Histories into Cancer Research: An Overview: F Boscoe, New York State Cancer Registry, Albany, NY, United States
1D25038Use of Residential Histories in Exposure Reconstruction and Space-Time Cancer Clustering: G Jacquez, University at Buffalo, Buffalo, NY, United States
1D35111Progress Toward a Life-Course Perspective in Cancer Surveillance Research: Incorporating Residential Histories into Population-Based Cancer Registries through Linkages with Public Records: A Stroup, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States, New Jersey State Cancer Registry, New Jersey Department of Health, Trenton, NJ, United States, Rutgers School of Public Health, Piscataway, NJ, United States
1D45046The Use of Residential Histories in Geospatial Research of Cancer: The Multiethnic Cohort Study: I Cheng, University of California, San Francisco, San Francisco, CA, United States
1D55019NCI Activities to Facilitate Residential History Research: Z Tatalovich, National Cancer Institute, Rockville, MD, United States
Concurrent 1-ENational Quality Control Initiatives
1E15069Setting the Standard: NPCR and SEER Join Forces to Establish Data Quality Benchmarks: S Negoita, National Cancer Institute, Rockville, MD, United States
1E250772017 National Program of Cancer Registries Data Quality Evaluation: S Manson, Centers for Disease Control and Prevention, Atlanta, GA, United States
1E35073The Data Quality Pre-evaluation Framework & Approach to SEER-wide Quality Audit Plan: Operational Results from Two Pilot Studies: D Dilts, Dilts+Partners, LLC, Nashville, TN, United States
1E45076SEER Quality Audit Plan: Proactive Quality Audit Plan Pilot Study: C Groves, Westat, Rockville, MD, United States
1E55075Reactive Quality Audit Pilot and Results: Quality Assurance Strategies for Cancer Surveillance: R Ehrenkranz, National Cancer Institute, Rockville, MD, United States
Concurrent 1-FStudent Session I
1F1S5215Molecular Characterization of the Mortality Disparity in Tobacco-Associated Appalachian HNSCC: B Papenberg, West Virginia University, Morgantown, WV, United States
1F2S5216The Prognostic Value of Negative Lymph Node Count and Lymph Nodes Ratio in Male Breast Cancer: K Elhusseiny, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
1F3S5010Nonclinical Factors Associated with Head and Neck Cancer Survivorship Among Patients with Metastatic Disease: N Osazuwa-Peters, Saint Louis University, Saint Louis/MO, United States
1F4S5219Improved Cancer Reporting Efficiency and Reduced Paper Waste: Lessons Learned from an Electronic Reporting Portal Recruitment Effort: E Stewart, University of California, Berkeley, Berkeley, CA, United States

Plenary Session #2: A Clear Path to the Legal Side

2PL1Establish and Use Legal Authority to Achieve Goals for Cancer Registration: A State Experience: Dr. Xiaocheng Wu, Louisiana Tumor Registry
2PL2Changing Laws to Collect E-Path in California: Dr. Dennis Deapen, Los Angeles Cancer Surveillance Program
2PL3Use of a Central IRB for Minimal Risk Study Reviews: Mr. Steve Friedman, MHSA, FAC-P/PM III, National Cancer Institute
NAACCR YOUNG Talk
NYT25107Automated Case identification and Coding at the Californian Cancer Registry: J Patrick, Health Language Analytics Global, Sydney, NSW, Australia

Concurrent Session #2

Concurrent 2-AEpidemiology II
2A15041Trends in Premature Cancer Mortality in the USA by Race/Ethnicity and County-Level Income Quintile: D Withrow, Radiation Epidemiology Branch, National Cancer Institute, Rockville, MD, United States
2A25028A Preliminary Assessment of Cancer Trends Using Data from NPCR-CSS: R Wilson, CDC, Cancer Surveillance Branch, Atlanta, GA, United States
2A35001Incident Cancers among Participants of the Alaska EARTH Study, and Associations with Known Cancer Risk Factor: S Nash, Alaska Native Tribal Health Consortium, Anchorage, AK, United States
2A45052Trends in Colorectal Cancer Incidence Among Younger Adults - Disparities by Subsite, Age, Sex, Race, Ethnicity, and Stage: A Crosbie, New Jersey Department of Health, Cancer Epidemiology Services, Trenton, NJ, United States
Concurrent 2-BGlobal Perspectives on Survival
2B15148A Comparison of Relative Survival with Cause-Specific Survival Using Updated Methods in the SEER Program: G Forjaz de Lacerda, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, United States
2B25113Comprehensive Cancer Survival Comparisons Across Seven Countries, 1995-2014: The ICBP SURVMARK2 Project: M Arnold, International Agency For Research On Cancer, Lyon, France
2B35133Women's Cancers: Prospects for a World-Wide High-Resolution Study: C Allemani, London School of Hygiene and Tropical Medicine, London, Great Britain
2B45015The American Cancer Society's Cancer Prevention Study-3: A Large-Scale Nationwide Prospective Cohort: A Deka, American Cancer Society, Atlanta, GA, United States
Concurrent 2-COn the Path to XML
2C14991The Path to Full XML Data Exchange Standard Implementation: I Hands, Kentucky Cancer Registry, Lexington, KY, United States
2C25043SAS and NAACCR XML Data Files: F Depry, Information Management Services, Inc., Calverton, MD, United States
2C35011Building an Ancillary System for Cancer Registries from SDC CAP Templates: J Seiffert, CyberData Technologies, Herndon, VA, United States
Concurrent 2-DBridging the Timeliness Gap
2D15140The Real-World Story of Real-Time Reporting: Findings from the NAACCR Assessment of Central Cancer Registry Timeliness and Reporting Task Force: A Stroup, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States, New Jersey State Cancer Registry, New Jersey Department of Health, Trenton, NJ, United States, Department of Epidemiology, Rutgers School of Public Health, Piscataway, NJ, United States
2D25062Childhood Cancer Data Collection: A Trend Analysis of Timeliness from NPCR-ECC (October 2012 - October 2017 Submissions): KB Zhang, ICF, Fairfax, VA, United States
2D35115Timeliness of Cancer Reporting at the Maryland Cancer Registry: W Ross, Westat, Rockville, MD, United States
2D45060Early Case Capture of Pediatric and Young Adult Cancers: A Comprehensive Examination of the Kentucky Cancer Registry's Early Case Capture Strategies: E Lycan, Kentucky Cancer Registry, University of Kentucky, Lexington, KY, United States
Concurrent 2-ECancer Disparities Tools: SEER HD*Calc Tool
2E15063Social Value Judgements in SES Disparities Assessment Using HD*Calc - Colorectal Cancer Mortality: D Lewis, National Cancer Institute, Bethesda, MD, United States
2E25061Using HD*Calc with Complex Survey Data: M Yu, National Cancer Institute, Bethesda, MD, United States
2E35067Demonstration of HD*Calc Using Examples of Mortality Data and Complex Survey Data: S Scoppa, IMS, Inc., Calverton, MD, United States
Concurrent 2-FStudent Session II
2F1S5218Changes in Health-Related Quality of Life in Older Women after Diagnosis with Gynecological Cancer: A Population-Based Analysis Using the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey: A Klapheke, University of California Davis, Davis, CA, United States
2F2S5212The Association Between Lifetime Screening for Cancer and Receipt of Annual Flu Vaccination: Are There Reinforcing Effects of Prevention Seeking?: I Watson, University of North Dakota - School of Medicine and Health and Sciences, Grand Forks, ND, United States
2F3S5083Disparities in Systemic Therapy Use in Advanced-Stage Non-Small Cell Lung Cancer (NSCLC) by Source of Health Insurance: F Maguire, University of California Davis Health, Institute for Population Health Improvement, Sacramento, CA, United States
2F4S5220Cancer Survivor Prevalence of Hepatobiliary Cancers in the SEER Population, 1975-2014: A Ayers, George Washington University, Washington, DC, United States
Birds of a Feather "Doing More with Less": Dr. Melanie Williams, Texas Cancer Registry; Gary Levin, Florida Cancer Data System

WEDNESDAY MAIN CONFERENCE

SectionAbstract NumberSession
6/13
CONFERENCE: Day 2
NAACCR Business Meeting

Concurrent Session #3

Concurrent 3-AEpidemiology III
3A15029The Devil's in the Data Details: National Program of Cancer Registries (NPCR) Component 2 Public Health Surveillance Pilot Projects on Prognostic Factors, Breast and Cervical Cancer Screening, and CIN III: P Pordell, Centers for Disease Control and Prevention, Atlanta, GA, United States
3A25131Racial Disparities in Uterine Corpus Cancer Survival in the United States by Age and Stage: K Miller, American Cancer Society, Inc., Atlanta, GA, United States
3A35025Monitoring the Impact of HPV Vaccine using Tissues from Central Cancer Registries (HPV Typing 2 Study): B Hallowell, Centers for Disease Control and Prevention, Atlanta, GA, United States
3A45033Ovarian Cancer Incidence and Survival in the United States by Subtype, Age, and Race/Ethnicity: L Torre, American Cancer Society, Atlanta, GA, United States
Concurrent 3-BEnvironmental & Occupational Epidemiology
3B15039Investigation of a Possible Link between Pollution from Military Facilities and Cancer on St. Lawrence Island, Alaska: D O'Brien, Alaska Cancer Registry, Anchorage, AK, United States
3B25071Did 9/11 Cause Cancer? The Role of the State Cancer Registry in Answering the Question: A Kahn, New York State Cancer Registry, Albany, NY, United States
3B35099Cancer Risk Among Florida Firefighters: D Lee, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, United States, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, United States, Florida Cancer Data System, University of Miami Miller School of Medicine, Miami, FL, United States
3B45081Malignant Mesothelioma Age-Adjusted Incidence Rates and Trends from the New Jersey State Cancer Registry (NJSCR) and the Surveillance, Epidemiology, and End Results (SEER) registries, 1992 - 2014: P Agovino, New Jersey Department of Health, Trenton, NJ, United States
Concurrent 3-CVirtual Pooled Registry Cancer Linkage System
3C15049Virtual Pooled Registry Cancer Linkage System: Building a Bridge to Streamlined IRB/Registry Application Processes for Multi-Registry Linkages: C Clerkin, NAACCR, Springfield, IL, United States
3C25059Web Portal for Virtual Pooled Registry Cancer Registry Linkage System (VPR-CLS): D Green, IMS Inc., Calverton, MD, United States
3C35048Using the Virtual Pooled Registry Cancer Linkage System for Interstate Deduplication, Results from Second Pilot Test: C Johnson, Cancer Data Registry of Idaho, Boise, ID, United States
3C45101Linkage of the U.S. Radiologic Technologists (USRT) Cohort with Nationwide NAACCR Cancer Registries: Methods and Preliminary Results: A Landgren, Division of Cancer Epidemiology and Genetics, National Cancer Institute (DCEG, NCI), Rockville, MD, United States
Concurrent 3-DImproving Registry Operations
3D15027Recruitment and Retention: A Challenge for Central Cancer Registries: F Ross, Kentucky Cancer Registry, Lexington, KY, United States
3D25003Will Data Quality Suffer without Visual Editing Review of Resolve Patient Set Tasks?: N Lozon, Wayne State University, Detroit, MI, United States, Karmanos Cancer Institute, Detroit, MI, United States
3D35119NAACCR Pathology Laboratory Electronic Reporting Volume 5, Version 5: J Mazuryk, Cancer Care Ontario, Toronto, ON, Canada
3D45037Setting the Stage for Change: Upgrading the Physician Cancer Case Reporting Application in New York: A Austin, NYS Cancer Registry, Albany, NY, United States
Concurrent 3-EBreast Cancer
3E15044The Association of Breast Cancer Subtypes, Guideline-Concordant Treatment and Survival among Patients with Stage I-III Disease: M Hsieh, Louisiana Tumor Registry, School of Public Health, LSU Health Sciences Center, New Orleans, LA, United States
3E25016Triple-Negative Breast Cancer Incidence Across the United States: Correlations with Area-Level SES and Behaviors: J Moss, National Cancer Institute, Bethesda, MD, United States
3E35103Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status among U.S. Cases with African Ancestry by Place of Birth: H Sung, American Cancer Society, Atlanta, GA, United States
3E45139Examining Subsequent Occurrence and Outcomes of Estrogen-related Cancers (Breast and Thyroid) in Missouri Women: C Schmaltz, Health Management and Informatics, University of Missouri, Columbia, MO, United States, Missouri Cancer Registry and Research Center, University of Missouri, Columbia, MO, United States
NAACCR YOUNG Talk
5090Automated extraction and assignment of TNM stage to support cancer case consolidation: M Carter, Utah Cancer Registry, University of Utah, Salt Lake City, UT, United States

Plenary Session #3: New Paths to New Data and New Sources

3PL1Using Data from EMR's: The Rise of Nationwide Networks: Jitin Asnaani, BS, MBA, CommonWell
3PL2New Data and Approaches to Learn and Capture Recurrence Information: Dr. Angela Mariotto, National Cancer Institute
3PL3Using Structured Data Capture to Enhance Cancer Surveillance Data Collection: Sandy Jones, MDE, Centers for Disease Control and Prevention
Presentation of the Calum S. Muir Award, Constance Percy Award for Distinguished Service, Outgoing NAACCR Board Member Awards, Board Resolutions, and NAACCR Certification

THURSDAY MAIN CONFERENCE

SectionAbstract NumberSession
6/14
CONFERENCE: Day 3

Plenary Session #4: Cancer Surveillance Data for Cancer Control and Clinical Outcome Improvement

4PL1American Cancer Society CAN; How ACS CAN Uses Cancer Surveillance Data and Data Need to Promote Cancer Prevention and Control (including new legislations and increasing fund for cancer research and cancer registry) in the United States: Catherine McMahon, MPH, American Cancer Society Cancer Action Network, Inc.
4PL2Using Central Cancer Registries to Document the Impact of Novel Therapies in a Population-Based Setting: Dr. Chuck Wiggins, New Mexico Tumor Registry
4PL3Estimating the Current and Future Burden of Cancer in Canada: Identifying Opportunities for Prevention in the ComPARe Project: Dr. Darren R. Brenner, University of Calgary, Oncology and Community Health Science
4PL4Patient Reported Outcomes in Canada: Dr. Craig Earle, Canadian Partnership Against Cancer

Concurrent Session #4

Concurrent 4-AEpidemiology IV
4A15109Cancer Prevalence: the Benefits of a Centralised National Registry in Accurately Identifying Those Living with and Beyond Cancer: J Charnock, Macmillan Cancer Support, London, Great Britain, Public Health England, London, Great Britain
4A25118Are Missed Cases Contributing to the Decline in Prostate Cancer Incidence?: K Cronin, National Cancer Institute, Bethesda, MD, United States
4A35146Prostate Cancer Incidence, Mortality and Prostate-Specific Antigen (PSA)-based Screening Rates in Maine in Relation to Changes in U.S. Preventive Services Task Force (USPSTF) Prostate Screening Recommendations: D Yob, University of Southern Maine, Portland, ME, United States
4A45072Application of CiNA Data: Geographic Patterns in Lung Cancer Incidence: D Lewis, National Cancer Institute, Bethesda, MD, United States
Concurrent 4-BTools for Cancer Surveillance
4B15042Using SEER Data to Develop Synthetic Cancer Trajectories that Enable Cancer Research: S Michalak, Los Alamos National Laboratory, Los Alamos, NM, United States
4B25098Advancing Cancer Surveillance In Less Resourced Settings Through Adaptation Of Seer Analysis Tools: G Forjaz de Lacerda, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, United States
4B35012Bridging The Path To The Future Using A New Data Item Consolidation Tool: Registry Plus Consolidation Rules Editor: M Esterly, Booz Allen Hamilton, McLean, VA, United States
4B45130Implementing Telemetry Recording in Registry Software to Provide On-Going Performance Feedback: J Golabek, Artificial Intelligence in Medicine, Toronto, ON, Canada
Concurrent 4-CLinkage Tools and Deduplication
4C15070Evaluating Record Linkage Software Using Representative Synthetic Datasets: B Liu, National Cancer Institute, Bethesda, MD, United States
4C24988An Introduction to Fastlink for Probabilistic Record Linkage: A Alexandersson, Florida Cancer Data System, University of Miami, Miami, FL, United States
4C35145Linkage Adjudication Practices and Perspectives: a Quality Study in SEER Registries: V Petkov, National Cancer Institute, Rockville, MD, United States
4C45157Feasibility Of Deduplicating Deidentified Data Submitted To CDC's National Program Of Cancer Registries: S Van Heest, CDC, Atlanta, GA, United States
Concurrent 4-DGeospatial & Community Clusters
4D15080Cluster Bluster: Cancer Tends to Cluster Less than other Diseases and Conditions: F Boscoe, New York State Cancer Registry, Albany, NY, United States
4D25129Cancer Cluster Investigations The New Mexico Experience: A Meisner, New Mexico Tumor Registry, Albuquerque, NM, United States
4D35153Investigation of Ocular Melanoma An Aggressive Form of Rare Tumor Diagnosed Clinically: C Rao, North Carolina Central Cancer Registry, Raleigh, NC, United States
4D45036Availability of Cancer Treatment in Montana: Where are the Gaps?: H Zimmerman, Montana Department of Public Health and Human Services, Helena, MT, United States
Concurrent 4-EBiomarkers and Tissue Repositories
4E15144SEER Virtual Tissue Repository Initiative: Current Status and Future Goals: V Petkov, National Cancer Institute, Rockville, MD, United States
4E25065Requesting Diagnostic Tissue Specimens at the Registry Level: C Lefante, Louisiana Tumor Registry, New Orleans, LA, United States, Louisiana State University Health Sciences Center; School of Public Health, New Orleans, LA, United States
4E35114The Kentucky Cancer Registry: Our Journey towards Precision Cancer Surveillance: E Durbin, Kentucky Cancer Registry, Lexington, KY, United States | Markey Cancer Center/University of Kentucky, Lexington, KY, United States
4E45132Extract Breast Cancer Genetic Markers in Pathology Reports using Natural Language Processing: G Chennupati, Los Alamos National Laboratory, Los Alamos, NM, United States
Concurrent 4-FBridge Session - Roberto Clemente
4F15054Augmenting Smoking History in Cancer Registry Data through Health Administrative Claims Data: Q Chen, University of Kentucky, Lexington, KY, United States
4F25013Invasive Cancer Incidence Adjusted for Reporting Delay in the United States, 2000 - 2014: SD Singh, CDC, Atlanta, GA, United States
4F35152Evaluation of Geocoding Procedures in the National Program of Cancer Registries: AM Lavery, Centers for Disease Control and Prevention, Atlanta, GA, United States
4F44989Overall and Specific Cancer Mortality Rates among U.S. and Foreign-Born Persons: United States 2005-2015: B Hallowell, Centers for Disease Control and Prevention, Atlanta, GA, United States

Concurrent Session #5

Concurrent 5-ABrain Cancer
5A15045Evaluating the Completeness of WHO Grade for Brain and Central Nervous System Tumors in the U.S., 2010 - 2014: M Hsieh, Louisiana Tumor Registry/Epidemiology Program, School of Public Health, LSU Health Sciences Center, New Orleans, LA, United States
5A25050Sunshine, Lollipops and Rainbows: Moving Forward Optimistically with the Cooperation and Collaboration that Achieved Collection of CNS Biomarkers: C Kruchko, Central Brain Tumor Registry of the United States, Hinsdale, IL, United States
5A35035Trends in Malignant Brain and Central Nervous System Tumor Incidence by Subtype among Children in the United States, 1998 - 2013: D Withrow, Radiation Epidemiology Branch, National Cancer Institute, Rockville, MD, United States
Concurrent 5-BPatient Reported Outcomes
5B15122PROM (Patient Reported Outcome Measure) Survey Suggests Some Men With Prostate Cancer May Be Unaware of Their Diagnosis: P Stacey, Public Health England, London, Great Britain
5B25032Web Compared to Paper Survey Response Outcomes among Individuals Diagnosed with Cancer: Assessing the Feasibility of Web Surveys for Obtaining Patient-Reported Outcomes: M Millar, Utah Cancer Registry, Salt Lake City, UT, United States, University of Utah Division of Epidemiology, Salt Lake City, UT, United States
5B35085Using Bi-Directional Reporting to Improve Clinical Care: R Rycroft, Colorado Central Cancer Registry, Denver, CO, United States
5B44999Cancer Survivor Perspectives on Providing Patient Reported Data to and Getting Information Back from Central Cancer Registries: T Smith, American Cancer Society, Atlanta, GA, United States
Concurrent 5-CLinkage Applications
5C15138Pilot Linkage of the Colorado Central Cancer Registry and the Colorado All Payer Claims Database: M Eguchi, University of Colorado Cancer Center, Denver, CO, United States
5C25097Linking Cancer Registries with Claims Data to Enable Community Oncology Reporting: C Fedorenko, HICOR, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
5C35034Linking Big (Federal) Data to State Cancer Registry Data for a Post-Marketing Drug Safety Surveillance Study: Challenges and Lessons Learned: D Harris, RTI Health Solutions, Research Triangle Park, NC, United States
5C45120Investigating Disparities in Cancer by Linking the Canadian Cancer Registry to Survey and Administrative Databases: A Collaboration between the Canadian Partnership Against Cancer and Statistics Canada: J Tung, Canadian Partnership Against Cancer, Toronto, ON, Canada
Concurrent 5-DData Visualization
5D15086Not Just a Pretty Picture: The U.S. Cancer Statistics Data Visualization Tool: S Singh, CDC, Atlanta, GA, United States
5D25066On the Fly Analysis and Visualization of Cancer Data Using Interactive Business Intelligence Dashboard: The Puerto Rico Central Cancer Registry Experience: C Torres-Cintron, Puerto Rico Central Cancer Registry, San Juan, Puerto Rico
5D35006Smart Mapping: Predominance of Cancer Incidence and Mortality and Proximity to National Cancer Institute (NCI)-Designated Cancer Centers: A Klapheke, Public Health Institute, Cancer Registry of Greater California, Sacramento, CA, United States
Concurrent 5-EMelanoma
5E15154Keep your Head out of the Clouds: Comparing Cutaneous Head and Neck Melanomas between a Mountainous and a Coastal Population: A Anderson-Mellies, University of Colorado Cancer Center, Aurora, CO, United States
5E25031Poor Prognosis for Thin Ulcerated Melanomas and Implications for a More Aggressive Approach to Treatment: M Hawkins, University of Colorado Cancer Center, University of Colorado, Aurora, CO, United States
5E35137Comparison of Characteristics, Treatment Patterns and Survival Outcomes of Primary GI Melanoma Cases to Cutaneous Melanoma and GI Carcinoma (SEER: 1973 - 2014): A Kahl, University of Iowa, Iowa City, IA, United States, Iowa Cancer Registry, Iowa City, IA, United States
5E44995Melanoma among Blacks in the United States: M Freeman, ORISE, Oak Ridge, TN, United States, CDC, Atlanta, GA, United States
Concurrent 5-FBridge Session - Rachel Carson
5F15007Identify Cancer Misdiagnoses Faster by Utilizing IBM Watson Explorer, a Natural Language Processing Tool: M Induni, Public Health Institute, Cancer Registry of Greater California, Sacramento, CA, United States
5F24998A New Cancer Research Data Source: NPCR and SEER Public Use Database 2001 - 2014: M O'Neil, Centers for Disease Control and Prevention, Atlanta, GA, United States
5F35104Tools for Data Analysis: Ohio's Public Health Information Warehouse: L Giljahn, Ohio Department of Health, Columbus, Ohio, United States

Plenary Session #5: Bridge to the Future - The NAACCR Showcase

Presidential Update
Virtual Pooled Registry Update

Use the search bar below to view by category. Options are “Operations”, “Data Use” and “Student”.

POSTER ABSTRACT PRESENTATIONS

Poster Number
Abstract Number
Title
Presenter
Institution
 
Country
Category
P-014985MatchPro - New platform for Probabilistic Record Linkage (or Teaching an Old Dog new Linkage Tricks)R. PinderUSC School of MedicineLos Angeles, CAUSOperations
P-025000Agreement between self-reported and tumor registry-recorded cancer among Alaska Native peopleS. NashAlaska Native Tribal Health ConsortiumAnchorage, AKUSOperations
P-035005Missed Cancer Cases from Texas Hospital Inpatient/Outpatient Data and Death Certificate Files: Combining Previously Separate ProcessesP. Miller-GianturcoTexas Cancer RegistryAustin, TXUSOperations
P-045053Doing less with more! Finding creative solutions for file storage and processing of Meaningful Use CDA FilesD. NgWestat, RockvilleRockville, MDUSOperations
P-055079Collection of active follow-up data in a NPCR registry: A review of the Patient-Centered Outcomes project at the New Hampshire State Cancer RegistryM. CelayaNew Hampshire State Cancer Registry, Geisel School of Medicine at DartmouthHanover, NHUSOperations
P-065088Can the CCR Leverage NLP for Quality Control Activities?S. WoodUC Davis HealthSacramento, CAUSOperations
P-075089Implementation of Natural Language Processing Applied to Pathology ReportsC. MoodyCalifornia Cancer Reorting and Epidemiologic Surveillance ProgramSacramento, CAUSOperations
P-085102SCAN 360
L. BouzoubaaSylvester Comprehensive Cancer Center, University of Miami Miller School of MedicineMiami, FLUSOperations
P-095106Enhancement of the Metro Chicago Breast Cancer Registry (MCBCR) Through Data LinkagesT.A. DolecekUniversity of Illinois at ChicagoChicago, ILUSOperations
P-105141Enhancing the completeness of birthplace data through linkage to death certificate data: an assessment from the California Cancer Registry DatabaseA. SipinLos Angeles Cancer Surveillance ProgramLos Angeles, CAUSOperations
P-115147API Errors on Central Registry Level: Successful or is there a Disconnect?J. MazrekuCalifornia Cancer RegistrySacramento, CAUSOperations
P-345116Innovative Sources for Breast Cancer: Supplementing Registry Multigene Assay Data Through LinkagesS. HillNew Jersey State Cancer Registry, Cancer Epidemiology Services, New Jersey Department of HealthTrenton, NJUSOperations
P-124992Opposing Trends in HPV-Associated Cancers in Massachusetts: Cervical and Oropharyngeal Cancers from 2006-2015S. GershmanMassachusetts Cancer RegistryBoston, MAUSData Use
P-134996Can a name reduce the risk of cancer?E. MillerNational Cancer InstituteRockville, MDUSData Use
P-145002Trends in the incidence of overweight- and obesity-associated cancers in Texas R. SardellTexas Cancer RegistryAustin, TXUSData Use
P-155008Human Subjects Protection and Cancer Surveillance Research: Revised Regulations, Expanded OpportunitiesR. McLaughlinPublic Health Institute, Cancer Registry of Greater CaliforniaSacramento, CAUSData Use
P-165009Characteristics and survival of children with acute leukemia with Down syndrome or other birth defects in New YorkB. QiaoNew York State Cancer RegistryMenands, NYUSData Use
P-175017Black-white disparities in colorectal cancer treatment, 2000 - 2007A. WhiteCenters for Disease Control and PreventionAtlanta, GAUSData Use
P-185018Breast cancer in young women ages 20-39 in the USC. DeSantisAmerican Cancer SocietyAtlanta, GAUSData Use
P-195021Prognostic Multigene Testing in Breast Cancer: Patterns, Disparities, and Opportunities for Advancing Standardized Patient CareV. CelayaGeisel School of Medicine at DartmouthHanover, NHUSData Use
P-205026An Assessment of Comorbid Health Conditions among Incident Cancer Diagnoses within the Virginia Cancer Registry, 2005-2014S. WangVirginia Dept. Of HealthRichmond, VAUSData Use
P-215040Recent trends in childhood cancer incidence in Canada (2001-2014): report from the Cancer in Young People in Canada (CYP-C) surveillance programL. XieCentre for Surveillance and Applied Research, Public Health Agency of CanadaOttawa, ONCAData Use
P-225051Trends in Incidence and Mortality of Liver Cancer in New Jersey ResidentsL. EberhartRutgers Cancer InstitueNew Brunswick, NJUSData Use
P-235055Incidence of Cancer in Adolescent and Young Adults in Puerto Rico: A Descriptive and Comparative StudyM. Alvarado OrtizPuerto Rico Central Cancer RegistrySan Juan, PRUSData Use
P-245057Risk of subsequent invasive cancers among cervical cancer survivors in New Jersey, 1990-2015KS. PawlishNew Jersey Department of Health, New Jersey State Cancer RegistryTrenton, NJUSData Use
P-255058Female Breast, Cervical and Colorectal Cancer Survival in Missouri, 1996-2014Y. YoshidaMissouri Cancer Registry & Research CenterColumbia, MOUSData Use
P-265068Stage at diagnosis by health insurance status among adolescent and young adult cancer patients in CaliforniaY. ChenCalifornia Cancer Reporting and Epidemiologic Surveillance ProgramSacramento, CAUSData Use
P-275074Three-Year Relative Survival for Gynecologic Cancers in Puerto Rico & USA Ethnic Groups: 2007-2011C.R. Torres-CintronPuerto Rico Central Cancer RegistrySan Juan, PRUSData Use
P-285082Rare Cancer Incidence in North Carolina (pancreas, male breast, adrenal / other endocrine glands)S. AliNorth Carolina Central Cancer RegistryRaleigh, NCUSData Use
P-295084Producing Cancer Statistics at the Census Tract Level: A Louisiana StoryL. ManiscalcoLouisiana Tumor RegistryNew Orleans, LAUSData Use
P-305087Contrary to the Popular Belief: Differential Impact of HRT and MPH Rules on Female Invasive Breast Cancer IncidenceA. BalamuruganArkansas Department of HealthLittle Rock, ARUSData Use
P-315092Cervical Cancer and Emergency Department Use in California from 2010 to 2014J.A. KillionCalifornia Cancer Reporting and Epidemiologic Surveillance ProgramSacramento, CAUSData Use
P-325110Competing Risks Survival and Cause of death in Female Breast Cancer Patients in KoreaH. ChoNational Cancer CenterGoyangSKData Use
P-335112What's behind the decreasing cervical cancer survival in the US?H.K. WeirCenters for Disease Control and PreventionAtlanta, GAUSData Use
P-355117Characteristics of Comorbidity Indices Derived from Health Administrative Claims Data for Younger and Older PatientsB. HuangUniversity of KentuckyLexington, KYUSData Use
P-365123Lung cancer survival in American Indians, Hispanics, and non-Hispanic Whites in New Mexico, USAZ. GalochkinaNew Mexico Tumor RegistryAlbuquerque, NMUSData Use
P-375127Worldwide Incidence of Colorectal cancer: a 10-year ForecastM. Hughes, J. OlabisiDecision Resources GroupBurlington, MAUSData Use
P-385159Building Linkage among Central Registration Systems - Uncover the Impact of HPV Immunization on Cervical Cancer IncidenceM. YouMichigan Department of Health and Human Services Division for Vital Records and Health StatisticsLansing, MIUSData Use
P-395142Patterns and Recent Trends in Mastectomy and Breast Conserving Surgery for Women with Early-Stage Breast Tumors in Missouri
C.L. SchmaltzMissouri Cancer Registry and Research CenterColumbia, MOUSData Use
P-1S5211The association between diabetes and depression among adults residing in Brazil: does it differ among cancer survivors when compared to the general population?I.W. WatsonUniversity of North Dakota - School of Medicine and Health and SciencesGrand Forks, NDUSStudent
P-2S5217Depressive Symptoms and Health-Related Quality of Life in Older Women with Gynecological Cancer: A Population-Based Analysis Using the Surveillance, Epidemiology, and End Results – Medicare Health Outcomes SurveyA.K. KlaphekeUniversity of California DavisDavis, CAUSStudent
P-3S5156Lifestyle-related risk factors for cancer and associations with social determinants of health: case study of the Cancer Risk Factors Atlas of Ontario in TorontoT.A. NorwoodUniversity of TorontoToronto, ONCAStudent
P-4S5213A Spatio-temporal Investigation of Breast Cancer Treatment Delay in MissouriJ. DuUniversity of Missouri-ColumbiaColumbia, MOUSStudent
P-5S5214Colorectal Cancer Survival in the Mountain West State of NevadaK.E. CallahanUniversity of Nevada Las VegasLas Vegas, NVUSStudent
P-6S4990Descriptive epidemiology of germ cell tumors in the central nervous system from 2005-2014H. GittlemanCase Comprehensive Cancer Center, CWRU School of MedicineCleveland, OHUSStudent
P-7S5047Data Collection Strategies and Survey Technology Preference in a SEER Rapid Response Surveillance Study (SEER RRSS) Offering No Participant IncentiveA. ReedWayne State UniversityDetroit, MIUSStudent

Copyright © 2018 NAACCR, Inc. All Rights Reserved | naaccr-swoosh-only See NAACCR Partners and Sponsors